Crystal unclear

Annals of the Rheumatic Diseases

Volumn 59, Issue 2, 2000, Pages 83-85

  Wong, P K K ^a   York, J R ^a   Ryan, D ^a   Sullivan, D ^a   McGill, N W ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PYROPHOSPHATE;

AGED; ARTICLE; CALCIUM BLOOD LEVEL; CASE REPORT; CHONDROCALCINOSIS; CLINICAL FEATURE; FEMALE; HUMAN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; WRIST DISEASE; WRIST RADIOGRAPHY;

AGED; CHONDROCALCINOSIS; CRYSTALLIZATION; DIAGNOSIS, DIFFERENTIAL; FEMALE; GOUT; HAND; HUMANS; LEG; XANTHOMATOSIS;

EID: 0034103822     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.59.2.83     Document Type: Article

References (16)

1. 1 Pritzker KPH, Phillips H, Luk SC, Koven IH, Kiss A, Houpt JB. Pseudotumour of the temporomandibular joint. J Rheumatol 1976;3:70-81.
2. 2 Ishida T, Dorfman HD, Bullough PG. Tophaceous pseudogout (Tumoral calcium pyrophosphate dihydrate crystal deposition disease). Hum Pathol 1995;26:587-93.
3. 3 Luisiri P, Blair J, Ellman MH. Calcium pyrophosphate dihydrate deposition disease presenting as tumoral calcinosis (periarticular pseudogout). J Rheumatol 1996;23:1647-50.
4. 4 Zunkeler B, Schelper R, Menezes AH. Periodontoid calcium pyrophosphate dihydrate deposition disease: "pseudogout" mass lesions of the craniocervical junction. J Neurosurg 1996,85:803-9.
5. 5 El-Khoury GY, Tozzi JE, Clark CR, Foucar E, Menezes AH, Smoker WRK. Massive calcium pyrophosphate crystal deposition at the craniovertebral junction. Am J Roentgenol 1985;145:777-8.
6. 6 Sissons HA, Stenier GC, Bonar F, May M, Rosenberg ZS, Samuels H, Present D. Tumoral calcium pyrophospahte deposition disease. Skel Radiol 1989,18:79-87.
7. 7 El-Khoury GY, Foucar E, Blair WF, Strottman MP, Malvitz TA, Smoker WRK. Case report 364. Skel Radiol 1986;15: 313-15.
8. 8 Leisen JCC, Austad ED, Bluhm GB, Sigler JW. The tophus in calcium pyrophosphate deposition disease. JAMA 1980; 244:1711-12.
9. 9 Ling D, Murphy WA, Kyriakos M. Tophaceous pseudogout. Am J Roentgenol 1982;138:162-5.
10. 10 Rodriguez MA, Paul H, Abadi I, Bravo JR, Armas P. Multiple microcrystal deposition disease in a patient with systemic lupus erythematosus. Ann Rheum Dis 1984;43:498-502.
11. 11 Ryan LM, McCarty D. Understanding inorganic pyrophosphate metabolism : toward prevention of calcium pyrophosphate dihydrate crystal deposition. Ann Rheum Dis 1995;54:939-41.
12. 12 Hensley CD, Lin JJ. Massive intrasynovial deposition of calcium pyrophosphate in the elbow. J Bone Joint Surg Am 1984;66-A:133-6.
13. 13 Utermann G. Apolipoprotein E polymorphism in health and disease. Am Heart J 1987;113 part 2:433-40.
14. 14 Kuo PT, Wilson AC, Kostis JB, Moreyra AB, Dodge HT. Treatment of type 3 hyperlipoproteinaemia with gemfibrozil to retard progression of coronary artery disease. Am Heart J 1988;116:85-90.
15. 15 Bardin T, Kuntz D. Primary hyperlipidaemias and xanthomatosis. In: Klippel JH, Dieppe PA, eds. Rheumatology. London: Mosby, 1998:8.30.1-3.
16. 16 Klemp P, Stansfield SA, Castle B, Robertson MC. Gout is on the increase in New Zealand. Ann Rheum Dis 1997;56: 22-6.